Advances in Charcot–Marie–Tooth Disease Research: Cellular Function of CMT-Related Proteins, Transgenic Animal Models, and Pathomechanisms
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Neurobiology of Disease
- Vol. 4 (3-4) , 215-220
- https://doi.org/10.1006/nbdi.1997.0148
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The phenotypic manifestations of chromosome 17p11.2 duplicationBrain, 1997
- Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22 Trembler on cell growth of NIH3T3 fibroblastsCell and tissue research, 1997
- Clinical Phenotypes of Different MPZ (P0) Mutations May Include Charcot–Marie–Tooth Type 1B, Dejerine–Sottas, and Congenital HypomyelinationNeuron, 1996
- Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNAHuman Molecular Genetics, 1996
- Full‐length Cloning, Expression and Cellular Localization of Rat Plasmolipin mRNA, a Proteolipid of PNS and CNSEuropean Journal of Neuroscience, 1996
- Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathiesNature Genetics, 1995
- Biology and Genetics of Hereditary Motor and Sensory NeuropathiesAnnual Review of Neuroscience, 1995
- Crucial Role for the Myelin‐associated Glycoprotein in the Maintenance of Axon‐Myelin IntegrityEuropean Journal of Neuroscience, 1995
- Null mutations of connexin32 in patients with X-linked Charcot-Marie-Tooth diseaseNeuron, 1994
- Mouse P0 gene disruption leads to hypomyelination, abnormal expression of recognition molecules, and degeneration of myelin and axonsCell, 1992